The Global In-Vitro Diagnostics Packaging Market was valued at USD 8.9 billion in 2025 and is estimated to grow at a CAGR of 5.5% to reach USD 14.9 billion in 2035.
Rising incidences of infectious diseases, growing home-based diagnostic solutions, and stricter regulatory standards for sterile and contamination-resistant packaging are key growth drivers. The market is also fueled by the rising need for cold chain-compatible packaging to maintain the stability of sensitive biological samples. Sustainability is emerging as a major trend, with manufacturers increasingly adopting recyclable, bio-based, and single-material packaging solutions to reduce environmental impact. Automation and high-speed packaging systems are reshaping operations, improving efficiency, and reducing human error, while portable and user-friendly designs support the growing adoption of decentralized and point-of-care testing across healthcare and research sectors.
The glass packaging is expected to grow at a CAGR of 6.2% during 2026-2035, owing due to its chemical inertness, thermal stability, and high purity, making it ideal for sensitive reagents and biological materials. Glass vials, ampoules, and containers are preferred in specialized diagnostic applications requiring minimal interaction between the material and its contents, supporting precision in pharmaceutical and laboratory testing.
The bottles & vials segment reached USD 2.8 billion in 2025. These formats are widely used for storing diagnostic reagents, culture media, and biological samples. Their compatibility with sterilization processes, automated dispensing systems, and cold chain requirements makes them essential in laboratories, hospitals, and centralized testing centers. Secure sealing, consistent sizing, and high chemical resistance ensure regulatory compliance and reliable diagnostic outcomes.
North America In-Vitro Diagnostics Packaging Market held a 35.1% share in 2025. The region’s growth is supported by strict regulations on sterility, contamination control, and cold chain management. Rising demand for rapid and point-of-care testing in healthcare and research sectors accelerates the adoption of advanced packaging solutions. Investments in scalable, automated, and eco-friendly packaging systems, along with smart packaging integration for temperature monitoring and supply chain traceability, reinforce North America’s leadership in the market.
Leading players in the Global In-Vitro Diagnostics Packaging Market include Amcor Limited, Corning Incorporated, Aptargroup Incorporated, Greiner Holding AG, VWR International, LLC., Focus Technology Co., Ltd., YuHuan KangJia, Labtech Disposables, Peacock Industries, Oliver, Abdos Labtech Private Limited, AdvaCare Pharma, ACADEMY MEDICAL INSTRUMENTS Limited Company, Ajosha Bio Teknik Pvt. Ltd., Amrit Scientific Ind. Private Limited and Zhuhai Ideal Biotech Co., Ltd. Companies in the In-Vitro Diagnostics Packaging Market are focusing on several key strategies to strengthen their market position. They are investing in research and development to design sustainable, recyclable, and bio-based packaging materials that comply with evolving environmental regulations. Expansion of automated and high-speed packaging solutions improves production efficiency and reduces human error. Firms enhance product portfolios with portable, user-friendly formats for point-of-care and home diagnostics. Strategic partnerships with healthcare providers and diagnostic companies enable broader market reach. Adoption of smart packaging for cold chain monitoring and traceability strengthens reliability and customer trust. Companies also leverage digital marketing, supply chain integration, and global distribution networks to increase accessibility and maintain a competitive advantage in this rapidly growing market.
This product will be delivered within 2-4 business days.
Rising incidences of infectious diseases, growing home-based diagnostic solutions, and stricter regulatory standards for sterile and contamination-resistant packaging are key growth drivers. The market is also fueled by the rising need for cold chain-compatible packaging to maintain the stability of sensitive biological samples. Sustainability is emerging as a major trend, with manufacturers increasingly adopting recyclable, bio-based, and single-material packaging solutions to reduce environmental impact. Automation and high-speed packaging systems are reshaping operations, improving efficiency, and reducing human error, while portable and user-friendly designs support the growing adoption of decentralized and point-of-care testing across healthcare and research sectors.
The glass packaging is expected to grow at a CAGR of 6.2% during 2026-2035, owing due to its chemical inertness, thermal stability, and high purity, making it ideal for sensitive reagents and biological materials. Glass vials, ampoules, and containers are preferred in specialized diagnostic applications requiring minimal interaction between the material and its contents, supporting precision in pharmaceutical and laboratory testing.
The bottles & vials segment reached USD 2.8 billion in 2025. These formats are widely used for storing diagnostic reagents, culture media, and biological samples. Their compatibility with sterilization processes, automated dispensing systems, and cold chain requirements makes them essential in laboratories, hospitals, and centralized testing centers. Secure sealing, consistent sizing, and high chemical resistance ensure regulatory compliance and reliable diagnostic outcomes.
North America In-Vitro Diagnostics Packaging Market held a 35.1% share in 2025. The region’s growth is supported by strict regulations on sterility, contamination control, and cold chain management. Rising demand for rapid and point-of-care testing in healthcare and research sectors accelerates the adoption of advanced packaging solutions. Investments in scalable, automated, and eco-friendly packaging systems, along with smart packaging integration for temperature monitoring and supply chain traceability, reinforce North America’s leadership in the market.
Leading players in the Global In-Vitro Diagnostics Packaging Market include Amcor Limited, Corning Incorporated, Aptargroup Incorporated, Greiner Holding AG, VWR International, LLC., Focus Technology Co., Ltd., YuHuan KangJia, Labtech Disposables, Peacock Industries, Oliver, Abdos Labtech Private Limited, AdvaCare Pharma, ACADEMY MEDICAL INSTRUMENTS Limited Company, Ajosha Bio Teknik Pvt. Ltd., Amrit Scientific Ind. Private Limited and Zhuhai Ideal Biotech Co., Ltd. Companies in the In-Vitro Diagnostics Packaging Market are focusing on several key strategies to strengthen their market position. They are investing in research and development to design sustainable, recyclable, and bio-based packaging materials that comply with evolving environmental regulations. Expansion of automated and high-speed packaging solutions improves production efficiency and reduces human error. Firms enhance product portfolios with portable, user-friendly formats for point-of-care and home diagnostics. Strategic partnerships with healthcare providers and diagnostic companies enable broader market reach. Adoption of smart packaging for cold chain monitoring and traceability strengthens reliability and customer trust. Companies also leverage digital marketing, supply chain integration, and global distribution networks to increase accessibility and maintain a competitive advantage in this rapidly growing market.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Packaging Product Type, 2022-2035 (USD Million)
Chapter 6 Market Estimates and Forecast, by Material Type, 2022-2035 (USD Million)
Chapter 7 Market Estimates and Forecast, by IVD Product Category, 2022-2035 (USD Million)
Chapter 8 Market Estimates and Forecast, by End Use, 2022-2035 (USD Million)
Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 (USD Million)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this In-Vitro Diagnostics Packaging market report include:- Amcor Limited
- Aptargroup Incorporated
- Corning Incorporated
- Greiner Holding AG
- Oliver
- VWR International, LLC.
- North America
- Globe Scientific Inc.
- Peacock Industries
- FUSION BIOTECH
- Asia-Pacific
- Abdos Labtech Private Limited
- ACADEMY MEDICAL INSTRUMENTS Limited Company
- Amrit Scientific Ind. Private Limited
- AdvaCare Pharma
- Focus Technology Co., Ltd.
- YuHuan KangJia
- Zhuhai Ideal Biotech Co., Ltd
- Ajosha Bio Teknik Pvt. Ltd.
- Europe
- Kindly (KDL) Group
- Labtech Disposables
- Narang Medical Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 285 |
| Published | March 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 8.9 Billion |
| Forecasted Market Value ( USD | $ 14.9 Billion |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
![IVD Labware Market by Product [Plastic, Glass], Type, Application, End User - Global Forecast to 2030 - Product Image](http://www.researchandmarkets.com/product_images/12894/12894573_60px_jpg/ivd_labware_market.jpg)
